Prognostic implications of minimal residual disease detection by second-look laparoscopy and circulating tumor DNA among patients with ovarian cancer after front-line therapy

Anne Knisely(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Lauren Cobb(The University of Texas MD Anderson Cancer Center), Shannon N. Westin(The University of Texas MD Anderson Cancer Center), Minetta C. Liu(Mayo Clinic), Jolyn Taylor, Punashi Dutta(Natera (United States)), Pamela T. Soliman(The University of Texas MD Anderson Cancer Center), Travis T. Sims(The University of Texas MD Anderson Cancer Center), David M. Boruta(Massachusetts General Hospital), Carly Bess Scalise(Medical University of South Carolina), Michaela Onstad Grinsfelder(The University of Texas MD Anderson Cancer Center), Lois M. Ramondetta(The University of Texas MD Anderson Cancer Center), Jeffrey How(The University of Texas MD Anderson Cancer Center), Bryan Fellman(The University of Texas MD Anderson Cancer Center), Nicole D. Fleming(The University of Texas MD Anderson Cancer Center), Sanghoon Lee(The University of Texas MD Anderson Cancer Center), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Roni Nitecki(The University of Texas MD Anderson Cancer Center), Gwyn Richardson(The University of Texas MD Anderson Cancer Center), Karen H. Lu(Moffitt Cancer Center), Adam Elnaggar(Natera (United States)), Pedro Ramirez(Houston Methodist), Aaron Shafer(The University of Texas MD Anderson Cancer Center)
Gynecologic Oncology
October 9, 2024
Cited by 1


Related Papers